Page last updated: 2024-12-08

imet 3146

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

IMET 3146: RN given refers to parent cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID134966
MeSH IDM0079440

Synonyms (14)

Synonym
32021-40-2
5-25-17-00018 (beilstein handbook reference)
zimet 31/64
(+-)-alpha-amino-5-(bis(2-chloroethyl)amino)-1-phenyl-1h-benzimidazole-2-propanoic acid
beta-(1-phenyl-5-bis-(beta-chloroethyl)amino-2-benzimidazolyl)-dl-alanine
(+-)-alpha-amino-5-(bis(2-chloroethyl)amino)-1-phenyl-2-benzimidazolepropionic acid
imet 3164
2-benzimidazolepropionic acid, alpha-amino-5-(bis(2-chloroethyl)amino)-1-phenyl-, (+-)-
brn 4019059
zimet-3164
imet 3146
31539-54-5
3-{5-[bis(2-chloroethyl)amino]-1-phenyl-1h-benzimidazol-2-yl}alanine
DTXSID80953520
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.50 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]